The Correlation of Urethral Pressure Profilometry Data in Women with Different Types of Urinary Incontinence

Шарипова, К К; Pilsetniece, Zane; Bekmukhambetov, Ye; Vjaters, Egils

doi:10.1159/000445807

Cited by 4 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was no standardized normal or SUI reference value for UPP. A non-athlete with SUI reported that her MUCP was 61.0 (43.5-78.5) cmH 2 O [23]; however, MUCP in our case report was lower. Recent studies indicate that intra-abdominal pressure increases to levels exceeding the intraurethral pressure during highmotion sports [24].…”

Section: Discussioncontrasting

confidence: 79%

Long-Term Improvement in Urinary Incontinence in an Elite Female Athlete Through the Laser Treatment: A Case Report

Okui¹,

Ikegami²,

Mikić³

et al. 2023

Cureus

View full text Add to dashboard Cite

Stress urinary incontinence (SUI) is increasing in elite female athletes (EFAs), affecting competition results and quality of life. Pelvic floor muscle training (PFMT) is the first-line treatment for SUI, and surgery is generally performed when PFMT is insufficient. However, in EFA, there are few cases in which surgery is performed and fewer reports. Therefore, there is no known general treatment strategy for EFA with SUI.In our study, a 23-year-old track-and-field medalist with severe SUI was successfully treated with a vaginal and urethral erbium-doped yttrium aluminum garnet laser (VEL + UEL). After 12 treatments over one year, urinary incontinence decreased from 300 mL or more in the 400 m track run before treatment to 0 mL. She did not experience any more problems during running or competition. There was no recurrence of SUI for three years, and the urethral pressure profile examination confirmed improvement.MRIs showed that the left puborectalis muscle was absent from the first visit. The urethra was oval with an anteroposterior outer diameter of 10 mm and a transverse outer diameter of 13 mm before treatment. However, after three years of treatment, both anteroposterior and transverse diameters became circular, measuring 11 mm. Vaginal wall thickness increased from 8 to 12 mm at the center of the height of the urethra, making it possible to support the urethra, and pretreated adipose tissue space between the urethra and vagina disappeared.It was noted that the uneven and fragile urethra/vagina, the presence of adipose tissue space, and the absence of the left puborectalis muscle may have been the cause of the SUI. One year of VEL + UEL treatment resulted in long-term improvement of SUI; MRI showed changes in the urethra and vagina.

show abstract

Section: Discussioncontrasting

confidence: 79%

Long-Term Improvement in Urinary Incontinence in an Elite Female Athlete Through the Laser Treatment: A Case Report

Okui¹,

Ikegami²,

Mikić³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…Kuralay Sharipova et al [ 6 ] included 130 patients with urinary incontinence (including 75 patients with simple SUI and 55 patients with simple urgency urinary incontinence). The MUCP of patients with simple SUI was 61.0 (43.5–78.5) cmH2O, significantly lower than 66.0 (52.0–96.0) cmH2O of patients with simple urgency urinary incontinence.…”

Section: Discussionmentioning

confidence: 99%

Feasibility of measuring urethral pressure during female midurethral slings

Meng

Wang²,

Zhang³

et al. 2020

Medicine

View full text Add to dashboard Cite

Rationale: Stress urinary incontinence (SUI) refers to the involuntary leakage of urine when abdominal pressure increases. Midurethral slings (MUS) have become the main surgical method for treating SUI, but no quantitative standard for the degree of sling tightness during operation exists. We achieved this quantitative measurement using ambulatory urodynamic equipment. Patient concerns: A 49-year-old woman presented to our hospital with intermittent urine leakage. Five pads were used daily to keep the vulva dry. The preoperative urethral pressure profilometry (UPP) showed that maximum urethral pressure (MUP) was 54 cmH2O and maximum urethral closure pressure (MUCP) was 53 cmH2O. Diagnosis: According to the medical history and examination findings, the patient was diagnosed as SUI. Interventions: The MUS and UPP were performed. Outcomes: The intraoperative UPP showed that MUP was 29 cmH2O and MUCP was 17 cmH2O. Three months after the operation, the patient was followed up by telephone. The amount of urine pad usage decreased from 5 pads/d to 0 pads/d, reaching the social control standard (0–1 pads/d). The patient's international consultation on incontinence questionnaire short form score decreased from 18 to 5, and their incontinence quality of life score increased from 12.5 to 78.4. The effect of urine control was satisfactory, and no complications occurred. Five months after operation, the patient was reexamined in the outpatient department. The UPP showed that the MUP was 98 cmH2O and the MUCP was 72 cmH2O. The patient still uses 1 pad/day. The international consultation on incontinence questionnaire short form score is 6 and incontinence quality of life score is 79.5. The curative effect is stable. Lessons: MUS has become an effective surgical method for SUI, and the tightness of the sling directly affects the surgical outcome. We have achieved the measurement of urethral pressure during MUS. However, although we found that there is no obvious clinical significance of urethral pressure measurement in MUS operation, future research will benefit from our findings by improving upon our study design to help standardize the clinical diagnosis and treatment of MUS.

show abstract

“…Women with a lower MUCP have a higher chance of experiencing SUI [25] and it would be interesting to see what influence Urolastic ® has on this parameter.…”

Section: Discussionmentioning

confidence: 99%

Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety

Vries

Breda²,

Fernandes³

et al. 2017

Urol Int

View full text Add to dashboard Cite

Introduction: Female stress urinary incontinence (SUI) is often treated surgically. Urethral bulking agents are a minimally invasive alternative, especially in patients suffering from intrinsic sphincter deficiency, but often with limited long-term efficacy. Urolastic® is a non-deformable, non-resorbable silicone elastomer that is used as an injectable. Its properties might result in a more durable response after injection. If this durability factor can be combined with a low complication rate, this can become a useful treatment option. We therefore assessed the subjective improvement and safety after treatment with Urolastic®. Materials and Methods: In 2 Dutch hospitals, 65 patients were treated with Urolastic®. The subjective improvement was assessed and the medical charts were reviewed for complications that appeared during the follow-up period. The complications were classified using the Clavien-Dindo classification. Results: We found that 76-88% of the patients showed subjective improvement at 12-25 months follow-up. The rate of improvement experienced was 50-70%. The rate of complications classified as Clavien-Dindo >II was 24-33%. The 12 patients with 75-100% subjective improvement after 2 months, showed 85% improvement after a median of 25 months. Conclusions: With careful patient selection, Urolastic® seems to be a safe, durable and effective treatment option for female SUI.

show abstract

The Correlation of Urethral Pressure Profilometry Data in Women with Different Types of Urinary Incontinence

Cited by 4 publications

References 4 publications

Long-Term Improvement in Urinary Incontinence in an Elite Female Athlete Through the Laser Treatment: A Case Report

Long-Term Improvement in Urinary Incontinence in an Elite Female Athlete Through the Laser Treatment: A Case Report

Feasibility of measuring urethral pressure during female midurethral slings

Para-Urethral Injections with Urolastic® for Treatment of Female Stress Urinary Incontinence: Subjective Improvement and Safety

Contact Info

Product

Resources

About